Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
AstraZeneca
Baxter
Boehringer Ingelheim

Last Updated: August 10, 2022

SOTYLIZE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Sotylize patents expire, and what generic alternatives are available?

Sotylize is a drug marketed by Azurity and is included in one NDA. There are three patents protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in SOTYLIZE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

Summary for SOTYLIZE
Drug patent expirations by year for SOTYLIZE
Drug Prices for SOTYLIZE

See drug prices for SOTYLIZE

Pharmacology for SOTYLIZE
Drug Class Antiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological Effect Cardiac Rhythm Alteration

US Patents and Regulatory Information for SOTYLIZE

SOTYLIZE is protected by four US patents.

Patents protecting SOTYLIZE

Sotalol compositions and uses of the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: INDICATED FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS, SUCH AS SUSTAINED VENTRICULAR TACHYCARDIA, THAT IN THE JUDGEMENT OF THE PHYSICIAN ARE LIFE-THREATENING

Sotalol compositions and uses of the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: SOTYLIZE IS INDICATED FOR THE MAINTENANCE OF NORMAL SINUS RHYTHM [DELAY IN TIME TO RECURRENCE OF ATRIAL FIBRILLATION/ATRIAL FLUTTER (AFIB/AFL)] IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM

Sotalol compositions and uses of the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Sotalol compositions and uses of the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: SOTYLIZE IS INDICATED FOR THE MAINTENANCE OF NORMAL SINUS RHYTHM [DELAY IN TIME TO RECURRENCE OF ATRIAL FIBRILLATION/ATRIAL FLUTTER (AFIB/AFL)] IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Harvard Business School
Moodys
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.